HISTOSONICS
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
HISTOSONICS
Industry:
Health Care Medical Medical Device
Founded:
2009-01-01
Address:
Plymouth, Minnesota, United States
Country:
United States
Website Url:
http://www.histosonics.com
Total Employee:
11+
Status:
Active
Contact:
(612) 351-0361
Email Addresses:
[email protected]
Total Funding:
126.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
InTouch Health
InTouch Health is the leader in Acute Care Telemedicine solutions.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
NinePoint Medical
NinePoint Medical is a transformational medical device company developing innovative, real-time, in vivo pathology devices.
NuPulseCV
NuPulse specializes in developing technology designed to treat patients with heart failure.
Silk Road Medical
Silk Road Medical provides research and development services of medical devices for neurovascular diseases.
Witting Innovation
Witting Innovation specializes in developing medical products, setting-up manufacturing and guiding clients through regulatory approval.
Current Advisors List
Current Employees Featured
Founder
Investors List
Venture Investors
Venture Investors investment in Series C - HistoSonics
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Series C - HistoSonics
Lumira Ventures
Lumira Ventures investment in Series C - HistoSonics
Yonjin Venture
Yonjin Venture investment in Series C - HistoSonics
Varian
Varian investment in Series C - HistoSonics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series C - HistoSonics
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series C - HistoSonics
Varian
Varian investment in Series C - HistoSonics
Fred Moll, M.D
Fred Moll, M.D investment in Series C - HistoSonics
Lumira Ventures
Lumira Ventures investment in Series C - HistoSonics
Official Site Inspections
http://www.histosonics.com Semrush global rank: 5.15 M Semrush visits lastest month: 1.57 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HistoSonics"
HistoSonics | Leader in Histotripsy
Jan 2, 2025 HistoSonics has developed a non-invasive, sonic beam therapy platform that uses histotripsy, which is capable of destroying targeted liver tumors at a sub-cellular level. What is …See details»
HistoSonics - Crunchbase Company Profile & Funding
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused …See details»
HistoSonics - Company Profile - Tracxn
Jan 2, 2025 HistoSonics is developing Histotripsy technology, licensed from the University of Michigan. It is a non-invasive, image guided therapeutic ultrasound system that excises tissue. …See details»
HistoSonics Announces $100 Million in Financings and …
Dec 13, 2022 HistoSonics also announced today the appointment of Erica Rogers, President and CEO of Silk Road Medical, Inc., to the company's Board of Directors. Rogers brings decades of leadership experience ...See details»
HistoSonics - Overview, News & Similar companies - ZoomInfo
Who is HistoSonics. HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a …See details»
Company Profile: The Reinvention of HistoSonics
Nov 27, 2019 Since starting their tenure at the company in 2017, President and CEO Mike Blue and Senior Medical Advisor Fred Lee, Jr., MD, have strategically re-envisioned and successfully transformed HistoSonics into a company that …See details»
HistoSonics Company Profile 2025: Valuation, Funding ... - PitchBook
HistoSonics was founded in 2009. Where is HistoSonics headquartered? HistoSonics is headquartered in Plymouth, MN. What is the size of HistoSonics? HistoSonics has 182 total …See details»
HistoSonics - Contacts, Employees, Board Members, Advisors
Organization. HistoSonics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 14. Contacts 69. About. …See details»
HistoSonics - VentureRadar
HistoSonics is a venture-backed medical device company developing a non-invasive robotic platform and novel beam therapy, Robotically Assisted Sonic Therapy (RASTSM). RAST uses …See details»
HistoSonics - Funding, Financials, Valuation & Investors
HistoSonics is funded by 20 investors. Venture Investors and Alpha Wave Ventures are the most recent investors. HistoSonics has a post-money valuation in the range of $500M to $1B as of …See details»
HistoSonics™ Partners with Li Ka Shing Foundation to Launch First ...
Aug 29, 2024 HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison™ Histotripsy System, announced today the company’s initial partnership in Asia with …See details»
HistoSonics Secures $102M Series D Financing
Minneapolis, MN, August 15, 2024 – HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today the completion of an …See details»
HistoSonics raises $102m to advance non-invasive histotripsy …
Aug 16, 2024 HistoSonics has secured $102m in an oversubscribed Series D financing round to advance its non-invasive histotripsy platforms and support commercial growth. The round, …See details»
Histosonics raises $102M for noninvasive treatment to destroy …
Aug 19, 2024 Dive Brief: Histosonics, whose technology targets liver tumors with ultrasound pulses delivered from outside the body, has raised $102 million in new funding to support …See details»
HistoSonics – International Society for Therapeutic Ultrasound
The HistoSonics team is bringing the power of histotripsy to patients and physicians across the world. Their mission and passion is to advance the novel science of histotripsy and its …See details»
Education Events - HistoSonics
Feb 20, 2024 Together, our investment in this partnership will help the organization realize the full potential of the Edison technology. Our Education Strategy. ... Central to the HistoSonics …See details»
Histotripsy Tumor Treatment Information | MyHistotripsy
Sep 12, 2024 You are leaving the HistoSonics® myhistotripsy.com website, which includes discussions on the benefits and risk of histotripsy and the indications for use statement for the …See details»
Hologic Completes Acquisition of Gynesonics, Inc.
Jan 6, 2025 Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical …See details»
Investigator Sponsored Research Program | HistoSonics
5 days ago HistoSonics is committed to supporting investigator-sponsored clinical studies involving the Edison System that are designed to provide valuable scientific and clinical …See details»
The Science - HistoSonics
Feb 19, 2024 The System should only be used by persons who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately …See details»